World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
49
Citations
7291
World Ranking
4366
National Ranking
99

Jorma Hinkula publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jorma Hinkula sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 199 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jorma Hinkula D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jorma Hinkula sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 49 D-Index — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jorma Hinkula is affiliated with Linköping University in Sweden and conducts research primarily in the fields of Medicine and Immunology and Microbiology. Their work encompasses several subfields, including Immunology, Epidemiology, Molecular Biology, Infectious Diseases, and Biomedical Engineering.

The research carried out by Hinkula covers a broad range of topics. Key areas of study include Immunotherapy and Immune Responses, SARS-CoV-2 and COVID-19 Research, Influenza Virus Research Studies, Immune Response and Inflammation, Respiratory Viral Infections Research, RNA Interference and Gene Delivery, and Nanoplatforms for Cancer Theranostics.

Recent papers authored or co-authored by Hinkula demonstrate focus on immunological approaches and nanotechnology applications in infectious disease contexts. These papers include:

  • Nano toolbox in immune modulation and nanovaccines, 2022, Trends in Biotechnology
  • Efficacy and Immune Response Elicited by Gold Nanoparticle-Based Nanovaccines against Infectious Diseases, 2022, Vaccines
  • Innate Immune Invisible Ultrasmall Gold Nanoparticles-Framework for Synthesis and Evaluation, 2021, ACS Applied Materials & Interfaces
  • SARS-CoV-2 Antibody Isotypes in Systemic Lupus Erythematosus Patients Prior to Vaccination: Associations With Disease Activity, Antinuclear Antibodies, and Immunomodulatory Drugs During the First Year of the Pandemic, 2021, Frontiers in Immunology
  • Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein, 2022, Vaccines

Publications by Hinkula have appeared frequently in several scientific journals, with the highest number in:

  • Vaccines
  • Research Square (Research Square)
  • ACS Applied Materials & Interfaces
  • Trends in Biotechnology
  • Frontiers in Immunology

Among frequent collaborators, Hinkula has co-authored multiple papers with Anirban Sengupta, Mohammad Azharuddin, Noha Al-Otaibi, Hirak K. Patra, and Claudia Devito, reflecting active involvement in interdisciplinary scientific cooperation.

Best Publications

  • Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

    Sandra Calarota;Göran Bratt;Siv Nordlund;Jorma Hinkula

  • Mucosal and Plasma IgA from HIV-1-Exposed Uninfected Individuals Inhibit HIV-1 Transcytosis Across Human Epithelial Cells

    Claudia Devito;Kristina Broliden;Rupert Kaul;Lennart Svensson

  • Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate.

    Claudia Devito;Jorma Hinkula;Rupert Kaul;Lucia Lopalco

  • Induction of specific T-cell responses in HIV infection

    Ann-Charlotte Leandersson;Göran Bratt;Jorma Hinkula;Gustav Gilljam

  • Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects.

    Claudia Devito;Jorma Hinkula;Rupert Kaul;Joshua Kimani

  • Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals.

    Antonio Cosma;Rashmi Nagaraj;Silja Bühler;Jorma Hinkula

  • Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment.

    Sandra A. Calarota;Ann Charlotte Leandersson;Göran Bratt;Jorma Hinkula

  • Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers.

    Kristina Broliden;Jorma Hinkula;Claudia Devito;Peter Kiama

  • Activation of Innate Immunity, Inflammation, and Potentiation of DNA Vaccination through Mammalian Expression of the TLR5 Agonist Flagellin

    Steven E. Applequist;Erik Rollman;Mark D. Wareing;Martin Lidén

  • Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the α-helix of gp41

    Mario Clerici;Claudia Barassi;Claudia Devito;Claudia Pastori

  • Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes.

    J Hinkula;C Svanholm;S Schwartz;P Lundholm

  • Humoral and cell-mediated immune responses in humans to the NSP4 enterotoxin of rotavirus.

    Kari Johansen;Jorma Hinkula;Felix Espinoza;Mikael Levi

  • Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics.

    Vivi-Anne Sundqvist;Jan Albert;Eva Ohlsson;Jorma Hinkula

  • Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice

    Jorma Hinkula;Jorma Hinkula;Stéphanie Devignot;Stéphanie Devignot;Sara Åkerström;Helen Karlberg

  • Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120.

    Lennart Åkerblom;Jorma Hinkula;Per-Anders Broliden;Barbro Mäkitalo

  • Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery.

    Andreas Bråve;Andreas Bråve;Karl Ljungberg;Andreas Boberg;Andreas Boberg;Erik Rollman;Erik Rollman

  • Enhanced immune responses after DNA vaccination with combined envelope genes from different HIV-1 subtypes.

    Karl Ljungberg;Erik Rollman;Lars Eriksson;Jorma Hinkula

  • Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA.

    Peter Lundholm;Yusuke Asakura;Jorma Hinkula;Erik Lucht

  • Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity.

    Claudia Devito;Bartek Zuber;Ulf Schröder;Reinhold Benthin

  • Interactions of Single and Combined Human Immunodeficiency Virus Type 1 (HIV-1) DNA Vaccines

    Anne Kjerrström;Jorma Hinkula;Gunnel Engström;Vladimir Ovod

  • A nonsense mutation (428G-->A) in the fucosyltransferase FUT2 gene affects the progression of HIV-1 infection.

    Elin Kindberg;Bo Hejdeman;Göran Bratt;Britta Wahren

Frequent Co-Authors

Britta Wahren
Britta Wahren Karolinska Institute
Eric Sandström
Eric Sandström Karolinska Institute
Lennart Svensson
Lennart Svensson Karolinska Institute
Marie Larsson
Marie Larsson Linköping University
Olle Eriksson
Olle Eriksson Uppsala University
Kenji Okuda
Kenji Okuda Yokohama City University
Stefan Schwartz
Stefan Schwartz Lund University
Jan Albert
Jan Albert Karolinska Institute
Toomas Timpka
Toomas Timpka Linköping University
Volker Erfle
Volker Erfle Technical University of Munich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career pathways. Many students consider nursing programs due to their integral role in patient care and immunological health. Finding programs that balance quality with accessibility is key to success.

Students new to healthcare often look for lpn schools easy to get into, which can serve as a stepping stone into nursing or specialized immunology roles. Licensed Practical Nurse (LPN) programs typically offer a quicker pathway to entering the workforce while building foundational knowledge.

For advanced clinical roles, the easiest np program options provide routes that accommodate busy students or career changers without sacrificing quality. Nurse Practitioner (NP) programs often integrate immunology principles, especially for those focusing on infectious diseases or immunodeficiencies.

Specializing further, Mental Health Nurse Practitioner programs are crucial, especially given the immune system's connection with mental health. The top pmhnp programs help learners gain clinical experience essential for psychiatric and immunological care.

Cost is also a significant factor. Prospective students can explore the cheapest psych np programs to find affordable options that maintain solid educational standards, making advanced practice more accessible.

Best Scientists Citing Jorma Hinkula

Trending Scientists

Recently Published Articles